A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma.
- DOI
- 10.1080/14796694.2024.2442851
- Published
- 2025-01-14
- Container
- Future Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2024.2442851,
title = {A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma.},
author = {Schadendorf D and Dummer R and Flaherty KT and Robert C and Arance A and de Groot JWB and Garbe C and Gogas HJ and Gutzmer R and Krajsová I and Liszkay L and Loquai C and Mandalà M and Yamazaki N and Queirolo P and Guenzel C and Polli A and Thakur M and di Pietro A and Ascierto PA.},
year = {2025},
journal = {Future Oncol},
doi = {10.1080/14796694.2024.2442851},
url = {https://doi.org/10.1080/14796694.2024.2442851}
}RIS
TY - JOUR TI - A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma. AU - Schadendorf D AU - Dummer R AU - Flaherty KT AU - Robert C AU - Arance A AU - de Groot JWB AU - Garbe C AU - Gogas HJ AU - Gutzmer R AU - Krajsová I AU - Liszkay L AU - Loquai C AU - Mandalà M AU - Yamazaki N AU - Queirolo P AU - Guenzel C AU - Polli A AU - Thakur M AU - di Pietro A AU - Ascierto PA. PY - 2025 JO - Future Oncol DO - 10.1080/14796694.2024.2442851 UR - https://doi.org/10.1080/14796694.2024.2442851 ER -
APA
D, S., R, D., KT, F., C, R., A, A., JWB, D. G., C, G., HJ, G., R, G., I, K., L, L., C, L., M, M., N, Y., P, Q., C, G., A, P., M, T., A, D. P., & PA., A. (2025). A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma.. Future Oncol. https://doi.org/10.1080/14796694.2024.2442851
Source records
- europe-pmc · retrieved 2026-09-26T12:36:33.678Z